Pulse on MedTech: How the industry is adapting to thrive

The MedTech industry continues to show resilience and build value, reaching US$587 billion in its sixth consecutive year of unbroken top-line growth. Through groundbreaking advancements in areas such as cardiovascular health and artificial intelligence, the industry is pushing the boundaries of innovation, making medical devices smarter, smaller and more personalized.

However, MedTech also faces significant challenges, including increased input costs, reimbursement issues and a shifting sales environment. Additionally, smaller companies are navigating limited access to venture capital and public markets, complicating MedTech's innovation ecosystem.

Join us to explore our findings from the 18th annual EY Pulse of the MedTech Industry Report, along with insights on how the industry can adapt and continue to drive growth and profitability amid transformational change.

Topics discussed include:

• How findings from the EY Pulse of the MedTech Industry Report have translated into MedTech action, or inaction, in 2024
• What trends will shape MedTech activity heading into 2025
• Real-world implications, as well as successful strategies and lessons learned, from those spearheading transformative MedTech efforts

Panelists:

• Arda Ural, PhD, EY Americas Life Sciences Sector Leader | EY - US
  
• Catherine Hunter, National Leader, Life Sciences | EY Canada
• John Babitt, EY Americas MedTech Transactions Leader | EY - US
• Lynlee Brown, Partner, Indirect Tax-Global Trade | EY - US
• Mark Ginestro, Principal, Life Sciences, EY-Parthenon, Ernst & Young LLP